Scientists Develop Single-Injection Treatment for HIV Infection

Pictured is staining for engineered cells that secrete the antibody against HIV. Courtesy of Tel Aviv University

A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for patients with HIV. The study examined the engineering of type B white blood cells in the patient's body so as to secrete anti-HIV antibodies in response to the virus.

The study was led by Dr. Adi Barzel and PhD student Alessio Nehmad, both from the school of neurobiology, biochemistry and biophysics at the George S. Wise faculty of life sciences and the Dotan Center for Advanced Therapies in collaboration with the Sourasky Medical Center (Ichilov). The study was conducted in collaboration with additional researchers from Israel and the U.S.

The study was published in the journal Nature.